Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
George Yancopoulos currently holds 595,077 shares of REGENERON PHARMACEUTICALS, INC. (REGN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, George Yancopoulos has been a net seller of REGN stock. They have purchased $0 and sold $467.7M worth of shares.
George Yancopoulos's most recent insider trade was on Dec 31, 2025, when they sold 28,570 shares at $0.00 per share.
George Yancopoulos serves as Executive at REGENERON PHARMACEUTICALS, INC. (REGN). They have executed 389 insider transactions totaling $467.7M over their tenure at the company.
George Yancopoulos holds the position of Executive at REGENERON PHARMACEUTICALS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
George Yancopoulos has shown a selling trading pattern, with $0 in total purchases and $467.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by George Yancopoulos was on Feb 15, 2024, when they sold $117.9M worth of REGN shares. This transaction involved 123,601 shares at $953.83 per share.
George Yancopoulos currently owns 595,077 shares of REGENERON PHARMACEUTICALS, INC. (REGN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of George Yancopoulos's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. George Yancopoulos has 389 Form 4 filings on record as an insider at REGENERON PHARMACEUTICALS, INC..
Set alerts for George Yancopoulos and 40,000+ other insiders.